Introduction
To examine the utility of employing breast screening test sets internationally the data of 1,009 radiologists from the USA, UK and other European countries were examined as they inspected 20 carefully selected difficult recent screening cases. Some 720 UK radiologists, 247 American and 42 European radiologists took part. Whilst similar sensitivity scores between the three groups were found, the main difference was the lower specificity of the American radiologists reflecting their different recall clinical practice. It is argued that using test sets internationally provides participants with useful comparative performance information whilst also providing data on how the same cases are interpreted by radiologists from different countries.
In order to determine how radiologists from different countries respond to the same set of challenging test cases, a set of 20 FFDM cases were selected from the PERFORMS case database which had been reported by 720 UK participants. This set, named PERFORMS mini-lab, was also examined by two other groups: 247 US participants at a Breast Symposium (Orlando, 2015) , and 42 European participants at EUSOBI conference (London, 2015) . The correct recall of abnormal cases (sensitivity), the correct return to screen (specificity) and the percentage of correct hits of Area of Interest (AOI) were compared and shown as below: 
